A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma

Clinical trial NCT04038359 · COMPLETED

Trial details

NCT number: NCT04038359
Sponsor: SecuraBio
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent Non-Hodgkin Lymphoma

Start date: 2019-09-24
Primary completion: 2023-07-24
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.